• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[The technic of argon laser trabeculoplasty and its results].

作者信息

Kitazawa Y, Yamamoto T, Shirato S, Eguchi S

出版信息

Klin Monbl Augenheilkd. 1984 Apr;184(4):274-7. doi: 10.1055/s-2008-1054463.

DOI:10.1055/s-2008-1054463
PMID:6727252
Abstract

Argon laser trabeculoplasty (ALT) was performed on 130 eyes with primary open-angle glaucoma or capsular glaucoma. Three different methods of ALT were employed to determine if the methods itself affects the incidence of immediate postoperative rises in intraocular pressure (IOP). Thirty-five eyes received 100 burns over 360 degrees of the posterior trabecular meshwork; these were categorized as Group 1. Group 2 comprised 77 eyes given 50 burns over 180 degrees of the posterior meshwork. Group 3 consisted of 18 eyes treated with 50 burns over 180 degrees of the anterior trabecular meshwork. The duration of each burn was 0.2 s in Group 1 and 0.1 s in Groups 2 and 3. The power of each burn ranged from 700 to 1000 mW in each group. Immediate postlaser IOP rise was defined as a pressure elevation exceeding prelaser value by 5 mmHg or more. In Group 1 the incidence of IOP rise was 82%; it was 58% after the first session in Group 2, but only 22% in Group 3. A sustained, marked pressure rise was most frequently observed in Group 1 as compared with the other two groups. Other complications, including sustained iritis, peripheral anterior synechiae and hyphema, were seen most frequently in Group 1 and least frequently in Group 3. Successful control of IOP, defined as an IOP of less than 20 mmHg, was achieved in 37% in Group 1, 70% in Group 2 and 56% in Group 3. The follow-up period ranged from 1.5 to 52 months.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

相似文献

1
[The technic of argon laser trabeculoplasty and its results].
Klin Monbl Augenheilkd. 1984 Apr;184(4):274-7. doi: 10.1055/s-2008-1054463.
2
[Results of argon laser treatment of 100 eyes with open-angle glaucoma (trabeculoplasty, trabeculoretraction)].[氩激光治疗100例开角型青光眼(小梁成形术、小梁退缩术)的结果]
J Fr Ophtalmol. 1983;6(8-9):661-70.
3
Methods of argon laser trabeculoplasty, complications and long-term follow-up of the results.氩激光小梁成形术的方法、并发症及结果的长期随访
Jpn J Ophthalmol. 1985;29(2):198-211.
4
Comparison of long-term outcomes of selective laser trabeculoplasty versus argon laser trabeculoplasty in open-angle glaucoma.选择性激光小梁成形术与氩激光小梁成形术治疗开角型青光眼的长期疗效比较
Ophthalmology. 2004 Oct;111(10):1853-9. doi: 10.1016/j.ophtha.2004.04.030.
5
[Pressure reduction after selective laser trabeculoplasty with two different laser systems and after argon laser trabeculoplasty--a controlled prospective clinical trial on 284 eyes].[两种不同激光系统的选择性激光小梁成形术及氩激光小梁成形术后的眼压降低——284只眼的对照前瞻性临床试验]
Klin Monbl Augenheilkd. 2007 Mar;224(3):173-9. doi: 10.1055/s-2007-963014.
6
[Laser treatment for tightening the trabecular meshwork in open-angle glaucoma (trabeculoplasty)].[激光治疗开角型青光眼小梁网拉紧术(小梁成形术)]
Klin Monbl Augenheilkd. 1982 Nov;181(5):411-3. doi: 10.1055/s-2008-1055262.
7
Do any factors predict a favourable response to laser trabeculoplasty?
Aust J Ophthalmol. 1984 May;12(2):149-53.
8
Argon laser trabeculoplasty in open-angle glaucoma.
Jpn J Ophthalmol. 1982;26(4):374-86.
9
[Use of YAG-Selecta laser and argon laser in the treatment of open angle glaucoma].[YAG-Selecta激光和氩激光在开角型青光眼治疗中的应用]
Klin Oczna. 2000;102(2):129-33.
10
[Laser trabeculoplasty or goniotrepanation. A prospective comparative study].
Klin Monbl Augenheilkd. 1987 Feb;190(2):92-8. doi: 10.1055/s-2008-1050335.

引用本文的文献

1
Efficacy and safety of indomethacin 0.1% versus flurbiprofen 0.03% eyedrops in inflammation after argon laser trabeculoplasty. The Belgian Study Group on Glaucoma.
Doc Ophthalmol. 1994;85(3):287-93. doi: 10.1007/BF01664937.